Tuesday, 20 June 2017 12:27

Therachon Receives EMA and FDA Orphan Drug Designation for TA-46 for Achondroplasia

Written by 
Rate this item
(0 votes)
Read 618 times Last modified on Tuesday, 05 June 2018 14:04